Related Experiment Video
Updated: Dec 27, 2025
Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
Published on: July 3, 2025
Associations Between Systemic Omega-3 Fatty Acid Levels With Moderate-to-Severe Dry Eye Disease Signs and Symptoms at
Eric J Kuklinski1, Milton M Hom, Gui-Shuang Ying
1Ophthalmology (E.J.K., K.Y.K., P.A.A.), Icahn School of Medicine at Mount Sinai, New York, NY; Private Practice (M.M.H.), Azusa, CA; Ophthalmology (G.-S.Y., M.G.M.), University of Pennsylvania, Philadelphia, PA; Clinical Research Center (M.C.L.), University of California, Berkeley, CA; Program in Integrative Nutrition & Complex Diseases (R.S.C.), Texas A&M University, College Station, TX; Kennedy Krieger Institute (R.J., A.M.), Baltimore, MD; and Ophthalmology (P.A.A.), University of Tennessee, Memphis, TN.
Purpose:
Omega-3 (n-3) fatty acid supplementation is used to treat systemic inflammatory diseases, but the role of n-3 in the pathophysiology and therapy of dry eye disease (DED) is not definitive. We evaluated the relationship of systemic n-3 levels with signs and symptoms at baseline in the Dry Eye Assessment and Management (DREAM) Study.
Methods:
Blood samples from participants at baseline were analyzed for n-3 and n-6, measured as relative percentage by weight among all fatty acids in erythrocytes. Symptoms were evaluated using the Ocular Surface Disease Index. Signs including conjunctival staining, corneal staining, tear breakup time (TBUT), and Schirmer's test with anesthesia were also evaluated.
Results:
There was no correlation between the systemic n-3 levels and DED symptoms. When the associations with signs of DED were assessed, lower DHA levels were associated with higher conjunctival staining, with mean scores of 3.31, 2.96, and 2.82 for low, medium, and high levels of DHA, respectively (linear trend P=0.007). None of the other signs were associated with DHA or the other measures of n-3.
Conclusion:
Previous studies have found varying results on the role of n-3 supplementation with the signs and symptoms of DED. Among patients with DED enrolled in the DREAM Study, lower systemic n-3 levels were not associated with worse symptoms and most signs of DED.
Related Concept Videos
01:26Nephrotic Syndrome II : Assessment and Medical Management
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...